nMRCGP exam update - Evidence for aspirin use
Current situation. Read more
The findings come from a study of 1,087 patients with stage 3 colon cancer receiving chemotherapy, almost 18 per cent of who had one or more first-degree relatives who had suffered from the disease.
Over a median follow-up of five years and seven months, 29 per cent of those with a family history of colorectal cancer died or suffered from cancer recurrence, compared with 38 per cent of those without.
Separating the two risk factors out, the researchers found that having a family history of colorectal cancer reduced the risk of cancer recurrence by 26 per cent and death by 25 per cent.
Further analysis showed that the more relatives with colorectal cancer a patient had, the stronger the benefit. For example, those with two or more affected relatives had a 51 per cent lower risk of cancer recurrence or death than those without a family history.
Comment below and tell us what you think
Current situation. Read more
Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more
Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more
Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more
Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more
Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more
GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Cl... Read more
Thymoglobuline is an immunosuppressant for the prophylaxis of graft rejection in renal or heart tra... Read more
Tyverb (lapatinib) is an oral antineoplastic agent that may provide women with an alternative option... Read more
Comments
Only registered users may comment. Log in now or register for a free account.